Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging.
Sorafenib
angiogenesis
anti-angiogenic therapy
hepatocellular carcinoma
Journal
Journal of hepatocellular carcinoma
ISSN: 2253-5969
Titre abrégé: J Hepatocell Carcinoma
Pays: New Zealand
ID NLM: 101674775
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
07
2019
accepted:
24
12
2019
entrez:
20
5
2020
pubmed:
20
5
2020
medline:
20
5
2020
Statut:
epublish
Résumé
Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, usually occurring on a background of liver cirrhosis. HCC is a highly vascular tumor in which angiogenesis plays a major role in tumor growth and spread. Tumor-induced angiogenesis is usually related to a complex interplay between multiple factors and pathways, with vascular endothelial growth factor being a major player in angiogenesis. In the past decade, understanding of tumor-induced angiogenesis has led to the emergence of novel anti-angiogenic therapies, which act by reducing neo-angiogenesis, and improving patient survival. Currently, Sorafenib and Lenvatinib are being used as the first-line treatment for advanced unresectable HCC. However, a disadvantage of these agents is the presence of numerous side effects. A major challenge in the management of HCC patients being treated with anti-angiogenic therapy is effective monitoring of treatment response, which decides whether to continue treatment or to seek second-line treatment. Several criteria can be used to assess response to treatment, such as quantitative perfusion on cross-sectional imaging and novel/emerging MRI techniques, including a host of known and emerging biomarkers and radiogenomics. This review addresses the pathophysiology of angiogenesis in HCC, accurate imaging assessment of angiogenesis, monitoring effects of anti-angiogenic therapy to guide future treatment and assessing prognosis.
Identifiants
pubmed: 32426302
doi: 10.2147/JHC.S224471
pii: 224471
pmc: PMC7188073
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
77-89Informations de copyright
© 2020 Moawad et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Cancer Cell. 2011 Mar 8;19(3):347-58
pubmed: 21397858
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Oncologist. 2008 Feb;13(2):120-5
pubmed: 18305056
Radiographics. 2017 Nov-Dec;37(7):1994-2017
pubmed: 29131761
Biochemistry (Mosc). 2008 Jul;73(7):751-62
pubmed: 18707583
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Gastroenterol Hepatol (N Y). 2014 Mar;10(3):153-61
pubmed: 24829542
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153
J Hepatol. 2011 Oct;55(4):866-75
pubmed: 21338642
Lancet Oncol. 2019 Feb;20(2):282-296
pubmed: 30665869
ISRN Oncol. 2012;2012:421673
pubmed: 22655206
Biochem J. 2008 Apr 15;411(2):211-26
pubmed: 18363553
J Gastroenterol Hepatol. 2011 Jul;26(7):1201-6
pubmed: 21371120
Clin Mol Hepatol. 2014 Jun;20(2):218-22
pubmed: 25032190
Korean J Radiol. 2014 Sep-Oct;15(5):554-77
pubmed: 25246817
Liver Cancer. 2018 Mar;7(1):1-19
pubmed: 29662829
Cancer Cell Int. 2019 Jan 29;19:22
pubmed: 30718977
Lancet Oncol. 2009 Jan;10(1):25-34
pubmed: 19095497
Drugs Context. 2018 Jun 27;7:212533
pubmed: 30002715
Hepatology. 2018 Aug;68(2):723-750
pubmed: 29624699
Indian J Radiol Imaging. 2015 Apr-Jun;25(2):121-8
pubmed: 25969635
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2142-9
pubmed: 17656670
Br J Cancer. 2009 Mar 24;100(6):865-9
pubmed: 19240721
Nat Rev Clin Oncol. 2012 Feb 14;9(3):167-77
pubmed: 22330689
Hepatology. 2003 May;37(5):1105-13
pubmed: 12717391
Am J Epidemiol. 2002 Feb 15;155(4):323-31
pubmed: 11836196
Cell Cycle. 2012 Aug 1;11(15):2843-55
pubmed: 22801548
Arch Biochem Biophys. 2002 Feb 15;398(2):284-90
pubmed: 11831861
Am J Pathol. 2006 Feb;168(2):639-48
pubmed: 16436677
Abdom Imaging. 2011 Jun;36(3):300-14
pubmed: 21279353
Oncologist. 2019 Feb;24(Suppl 1):S3-S10
pubmed: 30819826
Diagn Interv Imaging. 2013 Dec;94(12):1187-204
pubmed: 24211260
J Hematol Oncol. 2013 Jul 10;6:51
pubmed: 23842041
Invest Radiol. 2012 Jan;47(1):11-7
pubmed: 21512396
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
Gastroenterology. 2004 Nov;127(5 Suppl 1):S1-4
pubmed: 15508071
Acta Pharmacol Sin. 2015 Feb;36(2):241-51
pubmed: 25557114
Hepatology. 2010 Jun;51(6):1972-8
pubmed: 20209604
Radiology. 2014 Aug;272(2):322-44
pubmed: 25058132
BMC Cancer. 2009 Jun 28;9:208
pubmed: 19558720
Cancer. 2009 Nov 1;115(21):4895-906
pubmed: 19637355
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3225-30
pubmed: 17296941
Science. 2005 Jan 7;307(5706):58-62
pubmed: 15637262
Hepatology. 2010 Jun;51(6):2020-9
pubmed: 20512990
Acta Radiol. 2018 Jul;59(7):765-772
pubmed: 28927298
N Engl J Med. 2018 Jul 05;379(1):54-63
pubmed: 29972759
Nat Rev Clin Oncol. 2009 Jun;6(6):315-26
pubmed: 19483738
Annu Rev Physiol. 1991;53:217-39
pubmed: 1710435
GE Port J Gastroenterol. 2019 Jul;26(4):260-267
pubmed: 31328140
Am J Pathol. 2015 Nov;185(11):2949-68
pubmed: 26348576
J Hepatol. 2012 Apr;56(4):908-43
pubmed: 22424438
Radiology. 2004 Sep;232(3):921-30
pubmed: 15247436
Eur Radiol. 2017 May;27(5):2086-2094
pubmed: 27488851
Genes Cancer. 2011 Dec;2(12):1097-105
pubmed: 22866201
Mech Dev. 2001 Nov;109(1):115-9
pubmed: 11677062
Oncology. 2011;81(5-6):372-80
pubmed: 22269894
Ann Surg. 2002 Mar;235(3):373-82
pubmed: 11882759
World J Gastroenterol. 2010 Apr 7;16(13):1598-609
pubmed: 20355238
AJR Am J Roentgenol. 2009 Dec;193(6):W482-9
pubmed: 19933622
Biochem Biophys Res Commun. 2019 May 21;513(1):1-7
pubmed: 30944079
Med Sci Monit. 2015 Feb 01;21:376-82
pubmed: 25640082
Adv Exp Med Biol. 2002;515:55-69
pubmed: 12613543
Pharmaceuticals (Basel). 2010 Mar 11;3(3):572-599
pubmed: 27713269
Hum Reprod. 2006 Jan;21(1):262-8
pubmed: 16172144
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
Nat Rev Mol Cell Biol. 2009 Mar;10(3):165-77
pubmed: 19234476
J Magn Reson Imaging. 2008 Aug;28(2):390-5
pubmed: 18666145
Open Access Maced J Med Sci. 2015 Dec 15;3(4):732-6
pubmed: 27275318
Pathology. 2014 Aug;46(5):416-23
pubmed: 24977735
Int J Cancer. 2011 Mar 15;128(6):1259-68
pubmed: 20506153
World J Gastroenterol. 2003 Jun;9(6):1144-55
pubmed: 12800214
Differentiation. 2007 Nov;75(9):843-52
pubmed: 17999742
J Histochem Cytochem. 1997 Jul;45(7):1005-19
pubmed: 9212826
Isr Med Assoc J. 2000 Jul;2 Suppl:37-45
pubmed: 10909416
Cancer Res. 2000 Dec 15;60(24):7163-9
pubmed: 11156426
Dig Dis. 2009;27(2):114-24
pubmed: 19546549
Am J Physiol Cell Physiol. 2002 May;282(5):C947-70
pubmed: 11940508
Abdom Radiol (NY). 2019 Jun;44(6):2116-2132
pubmed: 30798397
Hepatology. 2009 Feb;49(2):658-64
pubmed: 19177576
AJR Am J Roentgenol. 2009 Oct;193(4):W301-7
pubmed: 19770299
Oncotarget. 2017 Feb 28;8(9):16052-16074
pubmed: 28030802
Lancet. 2003 Dec 6;362(9399):1907-17
pubmed: 14667750
J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281
AJR Am J Roentgenol. 2008 Jan;190(1):W28-34
pubmed: 18094269
J Clin Gastroenterol. 2013 Jul;47 Suppl:S2-6
pubmed: 23632345
World J Gastroenterol. 2014 Mar 28;20(12):3125-34
pubmed: 24695624
Oncol Lett. 2018 Feb;15(2):2245-2251
pubmed: 29434931